<![CDATA[yangll_0的博客]]>https://blog.youkuaiyun.com/yangll_0zh-cnhttps://blog.youkuaiyun.com/<![CDATA[病人层次的”CMAP”——首个病人来源的癌症药物扰动基因表达信号数据库CDS-DB，助力癌症药物重定向、联合用药发现]]>https://blog.youkuaiyun.com/yangll_0/article/details/137602506https://blog.youkuaiyun.com/yangll_0/article/details/137602506yangll_0Wed, 10 Apr 2024 17:21:10 +0800<![CDATA[首个病人来源的癌症药物扰动基因表达信号数据库CDS-DB,助力揭示癌症药物在患者体内的MOA]]>https://blog.youkuaiyun.com/yangll_0/article/details/137603066https://blog.youkuaiyun.com/yangll_0/article/details/137603066yangll_0Wed, 10 Apr 2024 17:10:11 +0800<![CDATA[善用CTR-DB数据库，轻松揭示癌症药物抵抗机制，发现克服药物抵抗的联合用药！]]>https://blog.youkuaiyun.com/yangll_0/article/details/135651354https://blog.youkuaiyun.com/yangll_0/article/details/135651354yangll_0Wed, 17 Jan 2024 17:01:20 +0800<![CDATA[病人级别的CMAP，想用你就来！]]>https://blog.youkuaiyun.com/yangll_0/article/details/135097709https://blog.youkuaiyun.com/yangll_0/article/details/135097709yangll_0Wed, 20 Dec 2023 01:55:53 +0800<![CDATA[癌症用药响应预测标志物发现和验证的好帮手——癌症药物抵抗数据库CTR-DB，后悔没有早点开！详解！收藏！]]>https://blog.youkuaiyun.com/yangll_0/article/details/135093450https://blog.youkuaiyun.com/yangll_0/article/details/135093450yangll_0Tue, 19 Dec 2023 20:45:57 +0800<![CDATA[癌症治疗响应预测标志物发现和验证的有力用具CTR-DB]]>https://blog.youkuaiyun.com/yangll_0/article/details/134240226https://blog.youkuaiyun.com/yangll_0/article/details/134240226yangll_0Mon, 06 Nov 2023 10:20:01 +0800